Array BioPharma Inc. (ARRY) - NASDAQ
  • wilkinson99 | Send Message 1 Jul

    Premarket Top % Gainers: $AUMN 23%, $AXU 10%, $AAU 9%, $NUGT 7%, $ECR 7%, $USLV 6%, $JNUG $SILJ $SBGL $GPL $FSM $ARRY $GFI $EXK $MUX $AMPE
      • Colin Macleod | Send Message 7 Jun

        Handful of charts breaking through key support levels $JD $BIIB $CTLT $ARRY $XL $ZBH
          • Alexander Valtsev | Send Message 7 Jun

            $ARRY monthly 27.6% return may prove temporary and traders will have to give back those gains.
              • EP Vantage | Send Message 6 Jun

                Array To Test BRAF/MEK Combo In Colorectal Cancer $ARRY
                  • Colin Macleod | Send Message 4 Jun

                    $ARRY - Array Biopharma Inc - Independent Analysis Video
                      • Bret Jensen | Send Message 16 May

                        Biotech Daily Digest: Array BioPharma In Spotlight; Pain In Biotech Continues; Contest To Buyout... $ARRY
                          • wilkinson99 | Send Message 2 Feb

                            Missed EPS expectations: $ADM $ARRY $CIT $NMR $PBI $R $SPB $TWIN
                              • freefdawatchlist | Send Message 30 Jan

                       Earning play for Feb 1st - 5th: $ARRY, $WNC, $MPLX, $ATW, $TTWO, $NE, $GPRO, $DNKN, $CHTR, $FIT, $WETF
                                  • Michael Blake Kuritz | Send Message 6 Jan

                                    Annual Mkt for Melanoma is $1B and growing. ($GSK $BMY) MEK inhibitor plays: $ARRY $RXDX $EXEL $AZN $NVS $TECH
                                      • xNotreDamex | Send Message 16 Dec 2015

                                        $ARRY undervalued, and they just had a successful stage 3 drug trial for cancer... buy it, lol
                                          Company Description
                                          Array BioPharma Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its proprietary drug development pipeline focuses on the treatment of cancer and inflammatory disease... More
                                          Sector: Services
                                          Industry: Research Services
                                          Country: United States